Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Neurology Diabetes / Metabolic Rheumatology Gastroenterology Mental Health / Psychiatry Women's Health Dermatology Men's Health Rare Diseases
Clinical Trial ● Currently Recruiting NCT07192393

Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).

Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC). — Recruiting • Gastroenterology • NCT07192393.

📅 30 Mar 2026 ⏱ 2 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
NCT ID
NCT07192393
Start
2025-08-08
Completion
2027-10-31
ClinicaliQ Trial Snapshot
  • Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC). — Recruiting • Gastroenterology • NCT07192393.
  • Review the linked registry entry for study design, population, endpoints, and operational status.

Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

PREM-IMPACT is a UK-based observational study exploring how caring for a very premature baby-particularly one affected by necrotising enterocolitis (NEC)-impacts families over the first year after hospital discharge. NEC is a serious bowel disease that can occur in premature babies, often requiring surgery and prolonged hospitalisation. This study runs alongside the WHEAT International Trial, which investigates whether pausing or continuing milk feeds during blood transfusions affects the risk of NEC in very preterm babies. PREM-IMPACT acts as a nested economic evaluation of the WHEAT Trial, helping to understand whether different…

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Guideline
2023 EASL-EASD-EASO Clinical Practice Guidelines for MASLD
Gastroenterology · 30 Mar 2026
This EASL guideline addresses 2023 EASL-EASD-EASO Clinical Practice Guidelines for MASLD in Gastroenterology. Use it to review current recommendation wording, eligibility criteria,…
View guideline →
Clinical Brief
UKHSA and Stablepharma highlight breakthrough with fridge-free tetanus and diphtheria vaccine
Gastroenterology · UKHSA · 13 Mar 2026
Stablepharma has developed a thermostable tetanus and diphtheria vaccine requiring no cold-chain storage, addressing a critical logistical barrier to immunisation in resource-limited…
View brief →
Guideline
Hepatitis B (Chronic): Diagnosis and Management (NICE NG133)
Gastroenterology · 27 Mar 2026
Assess all newly diagnosed chronic hepatitis B patients with HBsAg, anti-HBc, HBeAg, anti-HBe, quantitative HBV DNA, ALT, and liver function tests before…
View guideline →
Guideline
Coeliac Disease: Recognition, Assessment and Management (NICE NG20)
Gastroenterology · 27 Mar 2026
Test for coeliac disease using tissue transglutaminase (tTG) IgA antibodies as first-line serology, with concurrent total IgA measurement; if IgA deficient, use…
View guideline →
Guideline
Irritable Bowel Syndrome in Adults: Diagnosis and Management (NICE CG61)
Gastroenterology · 27 Mar 2026
Offer structured dietary and lifestyle advice as first-line treatment, including consideration of a low FODMAP diet if standard measures are insufficient, before…
View guideline →
Clinical Brief
Taskforce set up to deliver urgent action on maternity
Gastroenterology · NHS England · 17 Mar 2026
Members confirmed for new Maternity and Neonatal Taskforce chaired by the Health and Social Care Secretary to deliver improvements on maternity. This…
View brief →